Blogs

Unequivocal statement is sufficient to trigger option to arbitrate

Emergency arbitrator award in a foreign seated arbitration found to be enforceable by the Singapore High Court

Energy Charter Treaty modernisation stalls following abstentions from EU States

Arbitration Insights

Absolute discretion? Absolutely!

Out with the old, in with the new: amending contracts under English law

A cautionary tale of the importance of keeping track of changes

Compact Contract

COP15 – A new framework for nature

Podcast- a global perspective on accelerating decarbonisation through infrastructure and carbon markets

COP15 - setting the scene

Countdown to COP and beyond

The OECD breaks new ground with historic declaration on government access to private sector data

EU top court rules that controllers must disclose actual identity of data recipients in response to data subject access request

Does the ICO's new transfer risk assessment tool offer a pragmatic solution to the Schrems II dilemma?

Digital Hub

ECB publishes supervisory priorities 2023-25

EU General Court clarifies its position on shareholders’ right to bring legal proceedings and annuls ECB decision

ECB consults on guide to qualifying holding procedures

ECB in focus

The long and winding road to DE&I in financial services

Remuneration Update – Reimagining the ratio between fixed and variable bank pay

Quiet quitting – new language, old problem

Employment Talk

High Court clarifies limits on collateral use of documents obtained by the FCA pursuant to a request for mutual legal assistance: FCA v (1) Papadimitrakopoulos (2) Gryparis [2022] EWHC 2792 (Ch)

Top ten challenges for white collar crime and investigations lawyers in 2023

What UK readers couldn’t get enough of in 2022 - the top five blog posts revealed

Investigations Insight

Why AI drug discovery deals are different from traditional pharma collaborations

New date for the proposal of a revised EU pharmaceutical legislation

European Commission investigation into Teva’s potential abuse of dominance – misuse of patent procedures and disparagement

Life Sciences